Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Drug Alcohol Depend. 2020 Jan 17;208:107859. doi: 10.1016/j.drugalcdep.2020.107859

Figure 1.

Figure 1.

Panel A: Drug (oxycodone or placebo) versus money ($10) self-administration in the active lorcaserin (10 mg BID; closed circles) versus the placebo lorcaserin (0 mg BID; open circles) condition assessed using a verbal choice procedure during Days 1–4. Panel B: Oxycodone (10 mg) self-administration using a progressive-ratio procedure (Day 5) in the active lorcaserin (10 mg BID; closed circles) versus the placebo lorcaserin (0 mg BID; open circles) condition following 4 days of access to placebo oxycodone or active oxycodone.